| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4 |
| Period of Report: 2/27/24 |
| Not Subject to Section 16? No |
| Issuer: |
| Issuer CIK: 1314102 |
| Issuer Name: EyePoint Pharmaceuticals, Inc. |
| Issuer Trading Symbol: EYPT |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1630864 |
| | Owner Name: Duker Jay S. |
| Reporting Owner Address: |
| | Owner Street 1: C/O EYEPOINT PHARMACEUTICALS, INC. |
| | Owner Street 2: 480 PLEASANT STREET |
| | Owner City: WATERTOWN |
| | Owner State: MA |
| | Owner ZIP Code: 02472 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: President and CEO |
| | Other Text: |
| Aff 10b5 One? No |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 2/27/24 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: G |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Timeliness: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 2,500.00 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 29,420.00 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 2/27/24 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: G |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Timeliness: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 2,500.00 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 22,500.00 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: I |
| | | Nature of Ownership: |
| Value: Family Trust |
| Footnote ID: F2 |
| Derivative Table: |
| Footnotes: |
| Footnote - F1: On February 27, 2024, the reporting person transferred owned shares of Common Stock of the Company to the Family Trust. |
| Footnote - F2: These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ Ron Honig, Attorney-in-Fact |
| Signature Date: 2/28/24 |
